These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 15842521

  • 1. Continuing metformin when starting insulin in patients with Type 2 diabetes: a double-blind randomized placebo-controlled trial.
    Douek IF, Allen SE, Ewings P, Gale EA, Bingley PJ, Metformin Trial Group.
    Diabet Med; 2005 May; 22(5):634-40. PubMed ID: 15842521
    [Abstract] [Full Text] [Related]

  • 2. Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial.
    De Jager J, Kooy A, Lehert P, Bets D, Wulffelé MG, Teerlink T, Scheffer PG, Schalkwijk CG, Donker AJ, Stehouwer CD.
    J Intern Med; 2005 Jan; 257(1):100-9. PubMed ID: 15606381
    [Abstract] [Full Text] [Related]

  • 3. Combined metformin and insulin therapy for patients with type 2 diabetes mellitus.
    Ponssen HH, Elte JW, Lehert P, Schouten JP, Bets D.
    Clin Ther; 2000 Jun; 22(6):709-18. PubMed ID: 10929918
    [Abstract] [Full Text] [Related]

  • 4. Effect of adding sitagliptin, a dipeptidyl peptidase-4 inhibitor, to metformin on 24-h glycaemic control and beta-cell function in patients with type 2 diabetes.
    Brazg R, Xu L, Dalla Man C, Cobelli C, Thomas K, Stein PP.
    Diabetes Obes Metab; 2007 Mar; 9(2):186-93. PubMed ID: 17300594
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin.
    Hermansen K, Kipnes M, Luo E, Fanurik D, Khatami H, Stein P, Sitagliptin Study 035 Group.
    Diabetes Obes Metab; 2007 Sep; 9(5):733-45. PubMed ID: 17593236
    [Abstract] [Full Text] [Related]

  • 6. [Combination treatment with insulin and metformin in type 2 diabetes. Improves glycemic control and prevents weight gain].
    Hermann LS, Melander A.
    Lakartidningen; 1999 Dec 15; 96(50):5616-9. PubMed ID: 10643226
    [Abstract] [Full Text] [Related]

  • 7. A randomized controlled trial examining combinations of repaglinide, metformin and NPH insulin.
    Davies MJ, Thaware PK, Tringham JR, Howe J, Jarvis J, Johnston V, Kitchener DL, Skinner TC, McNally PG, Lawrence IG.
    Diabet Med; 2007 Jul 15; 24(7):714-9. PubMed ID: 17403126
    [Abstract] [Full Text] [Related]

  • 8. Effect of metformin plus roziglitazone compared with metformin alone on glycaemic control in well-controlled Type 2 diabetes.
    Stewart MW, Cirkel DT, Furuseth K, Donaldson J, Biswas N, Starkie MG, Phenekos C, Hamann A.
    Diabet Med; 2006 Oct 15; 23(10):1069-78. PubMed ID: 16978370
    [Abstract] [Full Text] [Related]

  • 9. Addition of pioglitazone to stable insulin therapy in patients with poorly controlled type 2 diabetes: results of a double-blind, multicentre, randomized study.
    Davidson JA, Perez A, Zhang J, Pioglitazone 343 Study Group.
    Diabetes Obes Metab; 2006 Mar 15; 8(2):164-74. PubMed ID: 16448520
    [Abstract] [Full Text] [Related]

  • 10. Less weight gain and hypoglycaemia with once-daily insulin detemir than NPH insulin in intensification of insulin therapy in overweight Type 2 diabetes patients: the PREDICTIVE BMI clinical trial.
    Fajardo Montañana C, Hernández Herrero C, Rivas Fernández M.
    Diabet Med; 2008 Aug 15; 25(8):916-23. PubMed ID: 18959604
    [Abstract] [Full Text] [Related]

  • 11. Insulin glargine in combination with nateglinide in people with Type 2 diabetes: a randomized placebo-controlled trial.
    Dashora UK, Sibal L, Ashwell SG, Home PD.
    Diabet Med; 2007 Apr 15; 24(4):344-9. PubMed ID: 17298589
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: a 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
    Rosenstock J, Brazg R, Andryuk PJ, Lu K, Stein P, Sitagliptin Study 019 Group.
    Clin Ther; 2006 Oct 15; 28(10):1556-68. PubMed ID: 17157112
    [Abstract] [Full Text] [Related]

  • 13. Rationale and design of a clinical trial to evaluate metformin and colesevelam HCl as first-line therapy in type 2 diabetes and colesevelam HCl in prediabetes.
    Jones MR, Mudaliar S, Hernandez-Triana E, Unnikrishnan AG, Lai YL, Abby SL, Misir S, Jin X, Nagendran S.
    Curr Med Res Opin; 2009 Sep 15; 25(9):2239-49. PubMed ID: 19622007
    [Abstract] [Full Text] [Related]

  • 14. An RCT into calculating insulin start dose in type 2 diabetes.
    Jarvis J, Burden A, Burden ML.
    Nurs Times; 2009 Sep 15; 100(21):40-4. PubMed ID: 15192923
    [Abstract] [Full Text] [Related]

  • 15. The combination oral and nutritional treatment of late-onset diabetes mellitus (CONTROL DM) trial results.
    Reboussin DM, Goff DC, Lipkin EW, Herrington DM, Summerson J, Steffes M, Crouse RJ, Jovanovic L, Feinglos MN, Probstfield JL, Banerji MA, Pettitt DJ, Williamson J.
    Diabet Med; 2004 Oct 15; 21(10):1082-9. PubMed ID: 15384954
    [Abstract] [Full Text] [Related]

  • 16. Effects of metformin in patients with poorly controlled, insulin-treated type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial.
    Avilés-Santa L, Sinding J, Raskin P.
    Ann Intern Med; 1999 Aug 03; 131(3):182-8. PubMed ID: 10428734
    [Abstract] [Full Text] [Related]

  • 17. [Short-term and long-term effect of metformin in type 1 diabetics].
    Lacigová S, Rusavý Z, Kyselová P, Jankovec Z, Kárová R, Cechurová D.
    Vnitr Lek; 2001 Feb 03; 47(2):81-6. PubMed ID: 15635851
    [Abstract] [Full Text] [Related]

  • 18. Metformin in women with type 2 diabetes in pregnancy (MiTy): a multi-center randomized controlled trial.
    Feig DS, Murphy K, Asztalos E, Tomlinson G, Sanchez J, Zinman B, Ohlsson A, Ryan EA, Fantus IG, Armson AB, Lipscombe LL, Barrett JF, MiTy Collaborative Group.
    BMC Pregnancy Childbirth; 2016 Jul 19; 16(1):173. PubMed ID: 27435163
    [Abstract] [Full Text] [Related]

  • 19. A double-blind randomized study comparing the effects of continuing or not continuing rosiglitazone + metformin therapy when starting insulin therapy in people with Type 2 diabetes.
    Home PD, Bailey CJ, Donaldson J, Chen H, Stewart MW.
    Diabet Med; 2007 Jun 19; 24(6):618-25. PubMed ID: 17403121
    [Abstract] [Full Text] [Related]

  • 20. [Metformin. Mode of action and effect of monotherapy and combination therapy on glucose metabolism in type 2 diabetes].
    Christiansen AL, Madsbad S.
    Ugeskr Laeger; 2002 Apr 08; 164(15):2025-8. PubMed ID: 11985000
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.